Trevi Therapeutics has made significant strides in its development program for Haduvio, a treatment aimed at addressing ...

Cases of human metapneumovirus (HMPV), a virus which can cause respiratory illness, have been surging over the last few months.

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with ...

Q4 2025 Earnings Call March 17, 2026 4:30 PM EDTCompany ParticipantsJennifer Good - Co-Founder, CEO, President, ...

Resting and staying hydrated helps support recovery from acute bronchitis. Chronic bronchitis requires ongoing medical care for long-term symptoms. Antibiotics can treat bacterial bronchitis, but not ...

Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its approval.

New research suggests millions taking GLP-1 weight-loss injections could also face a greater risk of developing a chronic ...

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing with age.

Dr Punam Krishan has explained the symptoms of COPD that could be easily overlooked - and recommended you should see a doctor if you have a persistent cough lasting more than four weeks ...

Archana Koirala has done research with funding from the Australian Department of Health, Disability and Ageing, and NSW health. She is the chair of the Vaccination Special Interest Group and a ...

Anyone who has dealt with a lingering cough knows how quickly it can take over daily life. It interrupts conversations, disrupts sleep and makes even simple things like eating or drinking ...